Popular Articles

Cancer Specialists Back New Treatment For UK Patients
Trial reports of the Evolife range of products in France have pointed to significant benefits and enhanced quality of life for cancer patients who use the products before, during and after chemo or radiotherapy treatment. Evolife is a natural range of cosmetics that is 100% dedicated to the support care of cancer patients.
generic viagra online
UC Davis Researchers Visualize Formation Of A New Synapse
A protein called neuroligin that is implicated in some forms of autism is critical to the construction of a working synapse, locking neurons together like "molecular Velcro," a study lead by a team of UC Davis researchers has found.
News of the day
The Right Cardiovascular Care For The Right Patient At The Right Time: ACC Positions Quality At Center Of Health-Care Reform
The American College of Cardiology (ACC) - long at the forefront of quality initiatives - is taking a leading role in health care reform. In partnership with patients, lawmakers and payers, the ACC is setting a new standard for health care delivery, one that centers on increasing the quality of care and ensuring greater patient access and value.
Endocrinology

Study Finds Widespread Use Of Rotavirus Vaccine Can Protect Unvaccinated, Increase Age Of First Infection

New vaccines against rotavirus, "the leading cause of severe diarrhea in infants," can prevent or lessen the severity of an epidemic, protect unvaccinated children and increase the age of first infection, lessening the severity of the disease, according to a study published in the journal Science, Bloomberg reports (Olmos, 7/16). Rotavirus "is rarely fatal in the U.S., but remains a major killer of children in less developed countries," HealthDay News/The Atlanta Journal-Constitution writes (7/16). Using mathematical models, a team of U.S. researchers found that when 80 percent of children in a geographic area receive vaccination, "annual outbreaks of rotavirus would be less frequent and more unvaccinated children would be protected from the illness," Bloomberg writes (7/16). The researchers were able to validate the model"s predictions by using U.S. data from 2007-2008, which represent "when vaccination first reached appreciable coverage levels in the U.S.," according to a CDC release. "This research not only explains the effects of the U.S. rotavirus vaccination program, but also lays the foundation for understanding the tremendous life-saving benefits of vaccination in the developing world, where more than half a million children die from rotavirus each year," said study author Umesh Parashar of the CDC"s National Center for Immunization and Respiratory Diseases (7/16). CBC News adds: The study revealed that "there was little relation between the virus prevalence and climate or environmental conditions," but rather pointed to children as what the authors called "the "primary drivers of epidemics." They suggest vaccination of young children in areas with high birth rates could lead to a drop in the number of epidemics and the severity of the cases for all population groups" (7/16). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):